Podcast Episodes
Back to Search
Episode 218: Discussing The Cost of Cancer Drugs With Daniel Goldstein, MD
Season 2 Episode 218
The Uromigos discuss the cost of quality adjusted life years with Daniel Goldstein, MD, Senior Physician at the Davidoff Cancer Center of Rabin Medic…
3 years, 8 months ago
Episode 217: Rising Star: Vadim Koshkin and ADCs
Season 2 Episode 217
Peter O'Donnell makes a guest appearance.
3 years, 8 months ago
Episode 216: ADCs in Bladder Cancer With Petros Grivas, MD, PhD
Season 2 Episode 216
Petros Grivas, MD, PhD joins The Uromigos to discuss the use of antibody drug conjugates in bladder cancer, including enfortumab vedotin (EV) and the…
3 years, 9 months ago
Episode 215: Resumen cáncer de próstata y vejiga reunión Canarias
Season 2 Episode 215
Resumen cáncer de próstata y vejiga reunión Canarias
3 years, 9 months ago
Episode 214: Resumen de la reunión en las Islas Canarias sobre cáncer renal
Season 2 Episode 214
Resumen de la reunión en las Islas Canarias sobre cáncer renal
3 years, 9 months ago
Episode 213: IL-15RaFc superagonist in NMIBC
Season 2 Episode 213
Sam Chang describes the data for this agent in bladder cancer.
3 years, 9 months ago
Episode 212: What's coming in GU Cancers in 2023
Season 2 Episode 212
What's happening this year in GU cancer.
3 years, 10 months ago
Episode 211: CAR-T cell therapy in RCC
Season 2 Episode 211
Monty Pal describes his recent study presented at SITC.
3 years, 10 months ago
Episode 210: Christmas Prostate Cancer Debate - olaparib and abiraterone in selected or unselected patients
Season 2 Episode 210
Dan George and Silke Gillessen disagree amicably.
3 years, 10 months ago
Episode 209: Christmas Bladder Cancer Debate - Cisplatin vs carboplatin in bladder cancer
Season 2 Episode 209
Matt Galski defends cisplatin admirably.
3 years, 10 months ago